One-year survival cohort of patients with reduced ejection fraction heart failure in Iranian population: A single center study

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 129

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

این مقاله در بخشهای موضوعی زیر دسته بندی شده است:

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RYA-17-1_012

تاریخ نمایه سازی: 2 شهریور 1401

چکیده مقاله:

BACKGROUND: Cardiovascular diseases (CVDs) are one of the main concerns of health care systems. The aim of this study was to investigate the most important prognostic factors of heart failure (HF) and their survival outcomes in patients in Birjand, East of Iran.METHODS: A total of ۱۹۴ systolic HF patients hospitalized in Birjand Valiasr hospital were followed up for ۱۲ months in ۲۰۱۶, and those with reduced left ventricle ejection fraction (LVEF < ۵۰%) were included in this study. Kaplan-Meier and Cox proportional hazard analysis were used to determine the association of each factor with events.RESULTS: The mean age of patients was ۶۸.۲۳ ± ۱۳.۴۰ (۲۷-۹۵) years, and ۵۷.۲% (۱۱۱ out of ۱۹۴) were women. Mean survival time was ۲۹۴.۷ ± ۹.۹۲۴ days. Pervious history of myocardial infarction (MI) [۲.۱۴۱ (۱.۱۰۱-۴.۱۶۱)] increased the risk of cardiovascular hospitalization. Elevated blood levels of potassium [۲.۲۶۴ (۱.۴۳۸-۳.۵۶۴)] was found to be a risk factor for all-cause and cardiovascular mortality. Moreover, there was a reverse relationship between body height [۰.۹۴۲ (۰.۸۸۸-۰.۹۹۹)] and cardiovascular death. Patients with opium addiction [۴.۰۴۹ (۱.۳۱۰-۱۲.۵۱۶)] are at a higher risk of cardiovascular mortality. Lower levels of LDL-C [۰.۹۷۷ (۰.۹۶۰-۰.۹۹۶)] and living in rural areas [۳.۰۵۲ (۱.۰۳۹-۸.۹۶۴)] increased all-cause mortality levels. Lack of pervious history of chronic obstructive pulmonary disease (COPD) decreased cardiovascular hospitalization [۰.۲۶۵ (۰.۰۶۲-۱.۱۲۲)].CONCLUSION: In our study, serum potassium, LDL-C, and uric acid levels in patients with HF were identified as prognostic factors. The height of patients, which can be an indicator of the functional state of their respiratory system, and the history of COPD were also recognized as prognostic factors. Opium use and rural living were identified as social factors influencing patients' prognosis.

نویسندگان

Mahdi Abdollahi-Karizno

Medical Student, Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran

Neda Partovi

Assistant Professor, Cardiovascular Diseases Research Center AND Department of Cardiology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Vahid Noferesti

Medical Student, Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran

Naeem Ravanbakhsh

General Practitioners, Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran

Toba Kazemi

Professor, Razi Clinical Research Development Unit (RCRDU) AND Department of Cardiology, Cardiovascular Diseases Research Center, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran

Saeede Khosravi-Bizhaem

Cardiovascular Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Loscalzo J. Harrison's cardiovascular medicine ۳/E. New York, NY: McGraw-Hill ...
  • Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, ...
  • Fonarow GC. Refining classification of heart failure based on ejection ...
  • Longo D, Fauci A, Kasper D, Hauser S, Jameson J, ...
  • Heidenreich PA, Trogdon JG, Khavjou OA, Butler J, Dracup K, ...
  • Jan VM, Mushtaq M, Aslam K, Rather H, Aliae MS. ...
  • Iran Institute for Health Metrics and Evaluation. How is the ...
  • Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, ...
  • Ponte ML, Keller GA, Di Girolamo G. Mechanisms of drug ...
  • Fauci A, Kasper D, Loscalzo J, Jameson L, Hauser SL, ...
  • Harikrishnan S, Sanjay G, Agarwal A, Kumar NP, Kumar KK, ...
  • Goldberg RJ, Ciampa J, Lessard D, Meyer TE, Spencer FA. ...
  • Singh RB, Sharma JP, Rastogi V, Raghuvanshi RS, Moshiri M, ...
  • Tromp J, Ter Maaten JM, Damman K, O'Connor CM, Metra ...
  • Desai AS, Liu J, Pfeffer MA, Claggett B, Fleg J, ...
  • Aldahl M, Jensen AC, Davidsen L, Eriksen MA, Moller HS, ...
  • Patel RB, Tannenbaum S, Viana-Tejedor A, Guo J, Im K, ...
  • Collins AJ, Pitt B, Reaven N, Funk S, McGaughey K, ...
  • Hughes-Austin JM, Rifkin DE, Beben T, Katz R, Sarnak MJ, ...
  • McDonald B, Davis RP, Kim SJ, Tse M, Esmon CT, ...
  • Holme I, Aastveit AH, Hammar N, Jungner I, Walldius G. ...
  • Ingelsson E, Arnlov J, Sundstrom J, Zethelius B, Vessby B, ...
  • Varbo A, Nordestgaard BG. Nonfasting triglycerides, low-density lipoprotein cholesterol, and ...
  • Velavan P, Huan Loh P, Clark A, Cleland JG. The ...
  • Charach G, Rabinovich A, Ori A, Weksler D, Sheps D, ...
  • Rauchhaus M, Clark AL, Doehner W, Davos C, Bolger A, ...
  • Witte KK, Clark AL. Nutritional abnormalities contributing to cachexia in ...
  • Gerber Y, Weston SA, Enriquez-Sarano M, Berardi C, Chamberlain AM, ...
  • Mortality associated with heart failure after myocardial infarction: A contemporary ...
  • Jacob J, Tost J, Miro O, Herrero P, Martin-Sanchez FJ, ...
  • Cuthbert JJ, Kearsley JW, Kazmi S, Kallvikbakka-Bennett A, Weston J, ...
  • Sofer T, Moon JY, Isasi CR, Qi Q, Shah NA, ...
  • Harati H, Shamsi A, Firouzkouhi Moghadam M, Seyed Zadeh FS, ...
  • Khodneva Y, Muntner P, Kertesz S, Kissela B, Safford MM. ...
  • Davoodi G, Sadeghian S, Akhondzadeh S, Darvish S, Alidoosti M, ...
  • Maslov LN, Khaliulin I, Oeltgen PR, Naryzhnaya NV, Pei JM, ...
  • نمایش کامل مراجع